TNFSF10 and cancer: This study explores the application of therapeutic, focal ultrasound to noninvasively enhance the anti‐cancer effects of Tumor necrosis factor‐related apoptosis‐inducing ligand (TRAIL) as a targeted treatment for prostate cancer.